News & Events
September 12, 2016 - September 13, 2016
Applying Regulatory Science to Neonates: Second Annual Scientific Workshop at European Medicines Agency (EMA)Date: September 12-13, 2016 Location: European Medicines Agency, Canary Wharf, London Sponsors: Critical Path Institute and European Medicines Agency The International Neonatal Consortium (INC) organized a two day workshop at the European Medicines Agency (EMA) on September 12-13, 2016. Focused on applying regulatory science to neonates, INC members explored approaches that family and neonatal nursing......
May 1, 2016
Pediatric Academic Societies Meeting State of the Art PlenaryMay 1, 2016 3:30 PM – 5:30 PM Baltimore Convention Center Baltimore, Maryland Session Details: Global Efforts to Accelerate Neonatal Drug Development Session Number: 2665 PAS State of the Art Plenary Baltimore Convention Center ~ 337/338 Neonatologists and scientists interested in the pharmacology, pathophysiology, genetics, and treatment options for commonly encountered neonatal conditions. Chairs: Christine......
April 26, 2016
Workshop on Clinical Outcome Assessments (COAs) in Cancer Clinical TrialsApril 26, 2016 Sheraton Silver Spring Hotel 8777 Georgia Avenue Silver Spring, MD 20910 The Workshop on Clinical Outcome Assessments in Cancer Clinical Trials, was co-sponsored by the FDA’s Office of Hematology and Oncology Products and the Critical Path Institute’s Patient-Reported Outcome (PRO) Consortium. The workshop aimed to provide a forum for collaborative and productive......
March 31, 2016 - April 1, 2016
CAMD Digital Biomarkers ConferenceUse of Biosensors in Clinical Trials: Barriers & Solutions to the Current Landscape March 31 – April 1, 2016 Bethesda North Marriott Conference Center Interest in identifying, evaluating and qualifying innovative technologies for use in drug development is growing. While regulatory guidance documents exist for pursuing novel Drug Development Tools (DDTs) and Medical Devices Development......
October 15, 2015
Coalition Against Major Diseases and FDA 2015 Annual Scientific WorkshopOctober 15, 2015 FDA White Oak Campus CO-SPONSORED BY: Critical Path Institute U.S. Food and Drug Administration Overview and Objectives The Coalition Against Major Diseases (CAMD) is a public-private-partnership aimed at creating new tools and methods that can be applied to increase the efficiency of the development process of new treatments for Alzheimer’s disease......